Insulin gene : Organisation, expression and regulation

Diabetes and Metabolism

Volumn 22, Issue 3, 1996, Pages 164-173

  Dumonteil, E ^b   Philippe, J ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b NONE

Author keywords

cAMP; DNA binding proteins; Glucose; Insulin gene transcription; Promoter

Indexed keywords

CYCLIC AMP; DNA BINDING PROTEIN; GLUCOSE; INSULIN;

GENE EXPRESSION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; REVIEW;

ADULT; ANIMALS; BASE SEQUENCE; CYCLIC AMP; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOSE; HUMANS; INSULIN; ISLETS OF LANGERHANS; MOLECULAR SEQUENCE DATA;

EID: 0030001136     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Steiner DF, Chan SJ, Welsh MJ, Kwok SCM. Structure and evolution of the insulin gene. Annu Rev Genet, 1985, 19, 463-484.
2. Chan SJ, Episkopon V, Zeitlin S et al. Guinea pig preproinsulin gene : an evolutionary compromise ? Proc Natl Acad Sci (USA), 1984, 81, 5046-5050.
3. Seino S, Welsh M, Bell GI, Chan SJ, Steiner DF. Mutations in the guinea pig preproglucagon gene are restricted to a specific portion of the prohormone sequence. FEBS Lett, 1986, 203, 25-30.
4. Owerbach D, Bell GI, Rutter WJ, Shows TB. The insulin gene is located on chromosome 11 in humans. Nature, 1980, 286, 82-84.
5. Davies PO, Poirier C, Deltour L, Montagutelli X. Genetic reassignment of the insulin-1 (Ins-1) gene to distal mouse chromosome 19. Genomics, 1994, 21, 665-667.
6. Soares MB, Schon E, Henderson E et al. RNA-mediated gene duplication : the rat preproinsulin is a functional retroposition. Mol Cell Biol, 1985, 5, 2090-2103.
7. Wentworth B, Schaefer I, Villa-Komaroff L, Chirgwin J. Characterization of the two nonallelic genes encoding mouse preproinsulin. J Mol Evol, 1986, 23, 305-312.
8. Naggert JK, Fricker LD, Varlamov O et al. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nature Genet, 1995, 10, 135-142.
9. Deltour L, Leduque P, Blume N et al. Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Proc Natl Acad Sci (USA), 1993, 90, 527-531.
10. Giddings SJ, Carnaghi L. Rat insulin II gene expression by extraplacental membranes : a non-pancreatic source of fetal insulin. J Biol Chem, 1989, 264, 9462-9469.
11. Pérez-Villamil B, De La Rosa EJ, Morales AV, De Pablo F. Developmentally regulated expression of the preproinsulin gene in the chicken embryo during gastrulation and neurulation. Endocrinol 1994, 135, 2342-2350.
12. Giddings SJ, King CD, Harman KW, Flood JF, Carnaghi LR. Allele-specific inactivation of insulin 1 and 2, in the mouse yolk sac, indicates imprinting. Nature Genet, 1994, 6, 310-313.
13. Deltour L, Montagutelli X, Guenet JL, Jami J, Páldi A. Tissue- and developmental stage-specific imprinting of the mouse proinsulin gene, Ins2. Dev Biol, 1995, 168, 686-688.
14. Bennet ST, Lucassen AM, Gough SCL et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem variation at the insulin gene minisalellite locus. Nature Genet, 1995, 9, 284-292.
15. Herrera PL, Huarte J, Zufferey R et al. Ablation of islet endocrine cells by targeted expression of hormone promoter-driven toxigene. Proc Natl Acad Sci (USA), 1994, 91, 12999-13003.
16. Selden RF, Skoskiewics MJ, Burke-Howie K, Russel PS, Goodman HS. Regulation of the human insulin gene expression in trangenic mice. Nature, 1986, 321, 525-528.
17. Bucchini D, Ripoche MA, Stinnakre MJ et al. Pancreatic expression of human insulin in trangenic mice. Proc Natl Acad Sci (USA), 1986, 83, 2511-2515.
18. Walker MD, Edlund T, Boulet AM, Rutter WJ. Cell-specific expression controlled by the 5′-flanking region of insulin and chemotrypsin genes. Nature, 1983, 306, 557-561.
19. Edlund T, Walker MD, Barr PJ, Rutter WJ. Cell-specific expression of the rat insulin gene : evidence for a role of two distinct 5′-flanking elements. Science, 1985, 230, 912-916.
20. Dandroy-Dron F, Itier JM, Monthioux E, Bucchini D, Jami J. Tissue-specific expression of the rat insulin I gene in vivo requires both the enhancer and promoter regions. Differentiation, 1995, 58, 291-295.
21. German M, Ashcroft S, Docherty K et al. The insulin gene promoter : A simplified nomenclature. Diabetes, 1995, 44, 1002-1004.
22. Dandroy-Dron F, Monthioux E, Jami J, Bucchini D. Regulatory regions of rat insulin I gene necessary for expression in trangenic mice. Nucl Acid Res, 1991, 19, 4925-4930.
23. German MS, Wang J, Chadwick RB, Ŕutter WJ. Synergistic activation of the insulin gene by a LIM-homeodomain protein and a basic helix-loop-helix protein : building a functional insulin minienhancer complex. Genes Dev, 1992, 6, 2165-2176.
24. German MS, Moss LG, Wang J, Rutter WJ. The insulin and islet amyloid peptide genes contain similar cell-specific promoter elements that bind identical beta cell nuclear complexes. Mol Cell Biol, 1992, 12, 1777-1788.
25. Kadesch T. Helix-Loop-Helix proteins in the regulation of immunoglobulin gene transcription. Immunol Today, 1992, 13, 31-37.
26. Wright WE. Muscle basic helix-loop-helix proteins and the regulation of myogenesis. Curr Opin Gen Develop, 1992, 2, 243-248.
27. Therrien M, Drouin J. Cell-specific helix-loop-helix factor required for pituitary expression of the proopiomelanocortin gene. Mol Cell Biol, 1993, 13, 2342-2353.
28. Wang TC, Brand SJ. Islet cell-specific regulatory domain in the gastrin promoter contains adjacent positive and negative elements. J Biol Chem, 1990, 265, 8908-8914.
29. Wheeler MB, Nishitani J, Buchan AMJ et al. Identification of a transcriptional enhancer important for entero-endocrine and pancreatic islet cell-specific expression of the secretion gene. Mol Cell Biol, 1992, 12, 3531-3539.
30. Cordier-Bussat M, Morel C, Philippe J. Homologous DNA sequences and cellular factors are implicated in the control of glucagon and insulin gene expression. Mol Cell Biol, 1995, 15, 3904-3916.
31. Aronheim A, Ohlsson H, Park CW, Edlund T, Walker MD. Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic beta cells and lymphocytes. Nucl Acid Res, 1991, 19, 3893-3899.
32. Park CW, Walker MD. Subunit structure of cell-specific E box-binding proteins analysed by quantitation of electromobility shift. J Biol Chem, 1992, 267, 15642-15649.
33. Ohlsson H, Thor S, Edlund T. Novel insulin promoter- and enhancer-binding proteins that discriminate between pancreatic alpha- and beta-cells. Mol Endocrinol, 1991, 5, 897-904.
34. Murre C, Schonleber-McCow P, Baltimore D. A new DNA binding and dimerization motif in immunoglobin enhancer binding, daughterless, MyoD, and myc proteins. Cell, 1989, 56, 777-783.
35. Vierra CA, Nelson C. The pan basic helix-loop-helix proteins are required for insulin gene expression. Mol Endocrinol, 1995, 9, 64-71.
36. Robinson GLWG, Cordle SR, Henderson E, Weil PA, Teitelman G, Stein R. Isolation and characterization of a novel transcription factor that binds to and activates insulin control element-mediated expression. Mol Cell Biol, 1994, 14, 6704-6714.
37. Naya FJ, Stellrecht CMM, Tsai MJ. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev, 1995, 9, 1009-1019.
38. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id : a negative regulator of helix-loop-helix DNA binding proteins. Cell, 1990, 61, 49-59.
39. Robinson GLWG, Henderson E, Massari ME, Murre C, Stein R. c-Jun inhibits insulin control element-mediated transcription by affecting the transactivation potential of the E2A gene product. Mol Cell Biol, 1995, 15, 1398-1404.
40. Gehring WJ, Affolter M, Bürglin T. Homeodomain proteins. Annu Rev Biochem, 1994, 63, 487-526.
41. Ohlsson H, Karlsson K, Edlund T. IPF1, a homeo-domain-containing transactivator of the insulin gene. EMBO J, 1993, 12, 4251-4259.
42. Peers B, Leonard J, Sharma S, Teitelman G, Montminy MR. Insulin expression in pancreatic cells relies on cooperative interactions. Mol Endocrinol, 1994, 8, 1798-1806.
43. Leonard J, Peers B, Johnson T, Ferreri K, Lee S, Montminy MR. Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol, 1993, 7, 1275-1283.
44. Miller C, McGehee R, Habener J. IDX-1, a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J, 1994, 13, 1145-1156.
45. Peshavaria M, Gamer L, Henderson E, Teitelman G, Wright CV, Stein R. XIHbox 8, an endoderm-specific Xenopus homeodomain protein, is closely related to a mammalian insulin gene transcription factor. Mol Endocrinol, 1994, 8, 806-816.
46. Guz Y, Montminy MR, Stein R et al. Expression of murine STF-1, a putative insulin gene transcription factor, in β cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development, 1995, 121, 11-18.
47. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature, 1994, 371, 606-609.
48. Wang M, Drucker DJ. The LIM domain homeobox gene isl-1 is a positive regulator of islet cell-specific proglucagon gene transcription. J Biol Chem, 1995, 270, 12646-12652.
49. Rudnick A, Ling TY, Odagiri H, Rutter WJ, German M. Pancreatic beta cells express a diverse set of homeobox genes. Proc Natl Acad Sci (USA), 1994, 91, 12203-12207.
50. Shieh SY, Tsai MJ. Cell-specific and ubiquitous factors are responsible for the enhancer activity of the rat insulin II gene. J Biol Chem, 1991, 266, 16708-16714.
51. Stellrecht CM, Finegold MJ, DeMayo MJ, Tsai MJ. Tissue-specific activity of the rat insulin II gene enhancer, RIPE3, in trangenic mice. Proc 75th Annu Meeting of the Endocrine Society, Las Vegas, NV, p. 373, 1993.
52. Read ML, Smith SB, Docherty K. Insulin enhancer binding site 2 (IEB2 ; FAR) box of the insulin gene regulatory region binds at least three factors that can be distinguished by their DNA binding characteristics. Biochem J, 1995, 309, 231-236.
53. Leibiger IB, Schwartz T, Liebiger B, Walther R. Functional analysis of a newly identified TAAT-box of the rat insulin-II gene promoter. FEBS Lett, 1995, 362, 210-214.
54. Inoue H, Tanizawa Y, Permutt MA. Cloning and characterization of the human insulin promoter factor 1 (IPF1) gene, identification of a polymorphic microsatellite, and mapping to chromosome 13. Diabetes, 1995, 44, 74A.
55. Read ML, Clark AR, Docherty K. The helix-loop-helix transcription factor USF (upstream stimulating factor) binds to a regulatory sequence of the insulin gene enhancer. J Biochem, 1993, 295, 233-237.
56. Catignani-Kennedy G, German MS, Rutter WJ. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nature Genet, 1995, 9, 293-298.
57. Catignani-Kennedy G, Rutter WJ. Pur-1, a zinc-finger protein that binds to purine-rich sequences, transactivates an insulin promoter in heterologous cells. Proc Natl Acad Sci (USA), 1992, 89, 11498-11502.
58. Permutt MA. Insulin biosynthesis IV : Effect of glucose on initiation and elongation rates in isolated rat pancreatic islets. J Biol Chem, 1974, 249, 2738-2742.
59. Welsh M, Nielsen DA, MacKrell AJ, Steiner DF. Control of insulin gene expression in pancreatic beta cells and in an insulin-producing cell line, RIN-5F cells. Regulation of insulin mRNA stability. J Biol Chem, 1985, 260, 13590-13594.
60. Nielsen DA, Welsh M, Casadaban MJ, Steiner DF. Control of insulin gene expression in pancreatic beta cells and in an insulin-producing cell line, RIN-5F cells. Effect of glucose and cAMP on the transcription of insulin mRNA. J Biol Chem, 1985, 260, 13585-13589.
61. Philippe J, Pacheco I, Meda P. Insulin gene transcription is decreased rapidly by lowering glucose concentrations in rat islet cells. Diabetes, 1994, 43, 523-528.
62. Melloul D, Ben-Neriah Y, Carasi E. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc Natl Acad Sci (USA), 1993, 90, 3865-3869.
63. MacFarlane W, Read M, Gilligan M, Bujalska I, Dorcherty K. Glucose modulates the binding activity of the beta-cell transcription factor IUF1 in a phosphorylation-dependent manner. Biochem J, 1994, 303, 625-631.
64. Persaud SJ, Jones PM. Inhibition of glucose-stimulated insulin secretion by Ro 31-8220, a protein kinase C inhibitor. Endocrine, 1995, 3, 285-289.
65. German MS, Moss LG, Rutter WJ. Regulation of insulin gene expression by glucose and calcium in transfected primary islet cultures. J Biol Chem, 1990, 265, 22063-22066.
66. German MS, Wang J. The insulin gene contains multiple transcriptional elements that respond to glucose. Mol Cell Biol, 1994, 14, 4067-4075.
67. Lefrançois-Martinez A-M, Martinez A, Antoine B, Raymondjean M, Kahn A. Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem, 1995, 270, 2640-2643.
68. Petersen HV, Serup P, Leonard J, Michelsen BK, Madsen OD. Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF1 acting through the CT boxes. Proc Natl Acad Sci USA, 1994, 91, 10465-10469.
69. Sharma A, Stein R. Glucose-induced transcription of the insulin gene is mediated by factors required for beta-cell-specific expression. Mol Cell Biol, 1994, 14, 871-879.
70. Alter CA, Wolf BA. Identification of phosphatidylinositol 3,4,5-trisphosphate in pancreatic islets and insulin-secreting beta-cells. Biochem Biophys Res Comm, 1995, 208, 190-197.
71. Rothenberg PL, Willison LD, Simon J, Wolf BA. Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting β-cells. Diabetes, 1995, 44, 802-809.
72. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes, 1995, 44, 863-870.
73. Girard J. Rôle des acides gras libres dans l'insulino-resistance du diabète non-insulino-dépendant. Diabete Metab, 1995, 21, 79-88.
74. Philippe J, Missotten M. Functional characterization of a cAMP-responsive element of the rat insulin I gene. J Biol Chem, 1990, 265, 1465-1469.
75. Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell, 1989, 59, 675-680.
76. Oetjen E, Diedrich T, Eggers A, Eckert B, Knepel W. Distinct properties of the cAMP-responsive element of the rat insulin 1 gene. J Biol Chem, 1994, 269, 27036-44.
77. Diedrich T, Knepel W. Interaction of the transcription factor CREB with pancreatic islet cell-specific enhancer elements. Biol Chem Hoppe-Seyler, 1995, 376, 39-44.
78. Inagaki N, Maekawa T, Sudo T, Ishii T, Seine S, Imura H. C-jun represses the human insulin promoter activity that depends on multiple cAMP response elements. Proc Natl Acad Sci (USA), 1992, 89, 1045-1049.
79. Fehmann HC, Habener JF. Galanin inhibits proinsulin gene expression stimulated by the insulinotropic hormone glucagon-like peptide 1 (7-37) in mouse insulinoma BTC-1 cells. Endocrinol, 1992, 130, 159-166.
80. Zhang IJ, Redmon JB, Andresen JM, Robertson RP. Somatostatin and epinephrine decrease insulin messenger ribonucleic acid in HIT cells through a pertussis toxin-sensitive mechanism. Endocrinol, 1991, 129, 2409-2414.
81. Philippe J. Somatostatin inhibits insulin-gene expression through a posttranscriptional mechanism in a hamster islet cell line. Diabetes, 1993, 42, 244-249.
82. Kawai K, Yokota C, Ohashi S, Watanabe Y, Yamashita K. Evidence that glucagon stimulates insulin secretion through its own receptor in rats. Diabetologia, 1995, 38, 274-276.